← All trials
NCT01101841
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2010
- Primary completion
- Sep 1, 2011
- Completion date
- Nov 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 570
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Noven TherapeuticsLead sponsor
- East Valley Family Physicians PLC, Chandler, AZOverall official - principal investigator
- Genesis Center For Clinical Research, San DiegoOverall official - principal investigator
- Women's Clinical Research Center, SeattleOverall official - principal investigator
- Department of Veteran AffairsOverall official - principal investigator
- Meridien ResearchOverall official - principal investigator
- Downtown Women's Health Care, Denver, COOverall official - principal investigator
- Montgomery Women's Health Associates, PC, Montgomery, ALOverall official - principal investigator
- Women's Clinic of LincolnOverall official - principal investigator
- Visions Clinical ResearchOverall official - principal investigator
- Chattanooga Medical Research, LLCOverall official - principal investigator
- Clinical Trials Research Services, LLCOverall official - principal investigator
- Hawthorne Medical Research, IncOverall official - principal investigator
- Philadelphia Clinical Research, LLCOverall official - principal investigator
- Phoenix Ob-Gyn Associates, LLC, Moorestown, NJOverall official - principal investigator
- The Clinical Trial Center, LLC, Jenkintown, PAOverall official - principal investigator
- Women's Medical Research Group, LLC, Clearwater, FLOverall official - principal investigator
- Altus ResearchOverall official - principal investigator
- SC Clinical Research Center, LLCOverall official - principal investigator
- Soapstone Center for Clinical ResearchOverall official - principal investigator
- University of Texas at HoustonOverall official - principal investigator
- Clinical Research Associates, Inc.Overall official - principal investigator
- Comprehensive Clinical Trials, LLCOverall official - principal investigator
- Mount Vernon Clinical Research, LLCOverall official - principal investigator
- National Clinical Research - Richmond, Inc.Overall official - principal investigator
- Anchor Research CenterOverall official - principal investigator
- Columbus Center for Women's Health Research, Columbus, OhioOverall official - principal investigator
- Rochester Clinical ResearchOverall official - principal investigator
- Chase Medical Research, LLCOverall official - principal investigator
- Apex BioscienceOverall official - principal investigator
- Coastal Carolina ResearchOverall official - principal investigator
- North Spokane Women's Clinic, Spokane, WA 99207Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.